Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Acid Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117430521A reveals Lewis acid catalysis for Glupa-C. Enhances purity and safety for reliable pharmaceutical intermediates supplier operations.
Novel three-step synthesis improves yield and purity for galactose derivatives. Cost-effective manufacturing process ensures reliable supply chain for pharmaceutical intermediates.
Patent CN108620103B reveals a novel solid acid catalyst enabling high-yield, optically pure synthesis of this critical pharmaceutical intermediate via direct dehydration.
Patent CN104447434B details a green catalytic oxidation method for p-carboxybenzenesulfonamide. Offers high purity, reduced waste, and scalable manufacturing for reliable pharmaceutical intermediate supply chains.
Patent CN101580498B details a water-based Paal-Knorr reaction using cation exchange resin. This method offers significant cost reduction in pharmaceutical intermediate manufacturing and superior supply chain reliability.
Patent CN1210248C reveals a superior Group 4 catalyzed esterification process offering high purity cyclopropane intermediates with reduced side reactions and enhanced supply chain reliability for global manufacturers.
Discover the patented CN101270038B method for synthesizing high-purity 4,4'-dihydroxybenzophenone using recycled carbon tetrachloride and solid superacid catalysts for cost-effective manufacturing.
Novel patent CN101270038B details a green synthesis of 4,4'-dihydroxybenzophenone using carbon tetrachloride and solid superacids, offering cost reduction and environmental compliance for pharmaceutical intermediates.
Patent CN110922427A reveals TMSOTf-catalyzed route for sterically hindered phosphonites. Green, solvent-free process offers cost reduction in pharma intermediate manufacturing.
Novel Ti-catalyzed method offers mild conditions and high yields for beta-aminocarboxylate production, ensuring cost-effective supply chain solutions.
Patent CN110016042B reveals a novel catalytic method for synthesizing dicoumarin derivatives, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN113603574B reveals a novel silicotungstic catalyst for cyclopentene oxidation offering high yield and recyclability for industrial glutaraldehyde manufacturing.
Novel Lewis acid catalyzed route offers mild conditions and high purity for complex heterocyclic pharmaceutical intermediates.
Novel Lewis acid catalysis method for EGFR inhibitor formula I ensures high purity and scalability. Reduced impurities offer reliable pharma intermediate supplier advantages for global procurement teams.
Patent CN103864637B reveals a mild TfOH-catalyzed route for N-(β-nitroalkyl) amides. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable methods.
Novel Lewis acid catalyzed synthesis offers high yield and safety for pharmaceutical intermediate manufacturing supply chains.
Novel acid-catalyzed acylcyanation of electron-rich alkynes. High selectivity, mild conditions. Cost-effective manufacturing for pharmaceutical intermediates.
Discover the novel synthesis of potential antiviral intermediate BL via patent CN115894498A. Offers high diastereoselectivity and scalable manufacturing for global supply chains.
Patent CN115894498A reveals a high-yield route for antiviral intermediate BL. Discover cost-effective manufacturing and scalable supply chain solutions for nucleoside analogs.
Patent CN118239888A reveals a light-induced modular synthesis for high-purity acridine compounds, offering significant cost reduction and supply chain reliability for photocatalyst manufacturing.